跳至主要内容
临床试验/NCT04568122
NCT04568122已完成不适用

Rapid Turnaround, Home-based Saliva Testing for COVID-19

Stanford University4 个研究点 分布在 1 个国家目标入组 1,277 人开始时间: 2020年11月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,277
试验地点
4
主要终点
Number of Matched Test Colormetric Interpretation as a Measure of Interrater Reliability

研究概览

简要总结

The aim of the study is to demonstrate the feasibility and validity of a saliva based home surveillance monitoring test for SARS-CoV-2 infection.

Participants will be asked to carry out as many tests as are included in the bag they are provided, on a daily basis until they are used up.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hospitalized patients
  • Hospitalized at Stanford Health Care for COVID-related complications and tested positive for SARS-CoV-2 with a PCR-based test
  • Able to understand and consent to study and with a clinical trajectory likely to be consistent with multi-day participation
  • High-risk/positive population
  • Seeking testing for suspected COVID or a participant in a study of COVID-positive outpatients
  • Own an internet-enabled phone or device capable of loading web pages, receiving text messages, and taking/uploading photos.
  • Willing to participate in the study for 6 months
  • Low-risk population
  • Own an internet-enabled phone or device capable of loading web pages, receiving text messages, and taking/uploading photos.
  • Willing to participate in the study for 6 months

排除标准

  • All participants:
  • Participants with salivary gland dysfunction (including patients with Sjogren's disease or those with xerostomia associated with lupus or rheumatoid arthritis)
  • Participants will not be eligible if they identify any reason they are unable to participate in the study
  • High-risk/positive population
  • Participants who have color blindness
  • Participants unable to operate the SnapDx device
  • Low-risk population
  • Participants with prior confirmed SARS-CoV-2 infection
  • Participants who have color blindness
  • Participants unable to operate the SnapDx device

结局指标

主要结局

Number of Matched Test Colormetric Interpretation as a Measure of Interrater Reliability

时间窗: Up to 5 days per participant

Feasibility Outcome. Discrepancy in interpretation of colormetric readout by participant versus by technician via photo. Passed test = void of manufacturing or user error.

Number of Positive Home Saliva Tests as Determined by the Patient

时间窗: Up to 5 days per participant

Validity Outcome.

次要结局

  • Participant-rated Ease of Use(Up to 5 days per participant)
  • Number of Participants That Called Technical Support(Up to 5 days per participant)
  • Participant-rated Confidence in Interpreting Results(Up to 5 days per participant)
  • Sample Integrity(Up to 5 days per participant)
  • Sensitivity of Sample Test Kit(Up to 5 days per participant)
  • Specificity of Sample Test Kit(Up to 5 days per participant)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Rapid Turnaround, Home-based Saliva Testing for... | 临床试验